The current valuation score of Werewolf Therapeutics Inc is 7.07, ranking 219 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.30, which is -12.78% below the recent high of -0.26 and -2456.96% above the recent low of -7.55.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.